NetworkNewsBreaks – Redfund Capital Corp. (CSE:
Post# of 36
(Total Views: 148)
Posted On: 01/18/2019 5:08:29 PM
NetworkNewsBreaks – Redfund Capital Corp. (CSE: LOAN) (OTC: PNNRF) (Frankfurt: O3X4) Builds Strong Portfolio Throughout 2018
Redfund Capital (CSE: LOAN) (OTC: PNNRF) (Frankfurt: O3X4) advanced throughout 2018 by employing a business strategy to create the foundations of a loan portfolio that produces revenue with monthly interest income and that also produces value for shareholders. A recent article discussing the company reads, “In 2018, the company extended funds for five signed promissory notes. In addition, Redfund had 11 companies in the pipeline at various stages of due diligence. As of November, the Redfund loan portfolio consists of Winterlife, Mary’s Wellness, RxMM Health Care, Biominerales Pharma Colombia and Biolog Inc. . . . Based on its strategy, Redfund aims to provide debt and equity funding in the mid and later stages of the development of a target company. The current focus is medical cannabis, hemp and CBD-related health care/wellness companies.”
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
Redfund Capital (CSE: LOAN) (OTC: PNNRF) (Frankfurt: O3X4) advanced throughout 2018 by employing a business strategy to create the foundations of a loan portfolio that produces revenue with monthly interest income and that also produces value for shareholders. A recent article discussing the company reads, “In 2018, the company extended funds for five signed promissory notes. In addition, Redfund had 11 companies in the pipeline at various stages of due diligence. As of November, the Redfund loan portfolio consists of Winterlife, Mary’s Wellness, RxMM Health Care, Biominerales Pharma Colombia and Biolog Inc. . . . Based on its strategy, Redfund aims to provide debt and equity funding in the mid and later stages of the development of a target company. The current focus is medical cannabis, hemp and CBD-related health care/wellness companies.”
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
(0)
(0)Xtacy Therapeutics Corp. (XTCYF) Stock Research Links
Scroll down for more posts ▼